Table 2.
Top 10 reference instances found for profiles of hypoxia treated cells
| cMap ID | Molecule | Dose | Cell line | GO counts |
|---|---|---|---|---|
| 573 | Deferoxamine [INN] | 100 μM | MCF7 | 57(57+, 0−) |
| 904 | 5109870 | 25 μM | MCF7 | 57(57+, 0−) |
| 584 | Dimethyloxalylglycine | 1 mM | PC3 | 52(52+, 0−) |
| 1010 | Thioridazine [INN] | 10 μM | MCF7 | 49(49+, 0−) |
| 460 | Deferoxamine [INN] | 100 μM | PC3 | 48(48+, 0−) |
| 1053 | Prochlorperazine [INN] | 10 μM | MCF7 | 46(46+, 0−) |
| 485 | Deferoxamine [INN] | 100 μM | MCF7 | 42(42+, 0−) |
| 977 | Wortmannin | 1 μM | MCF7 | 42(42+, 0−) |
| 1001 | Sirolimus [INN] | 100 nM | MCF7 | 40(40+, 0−) |
| 913 | Colforsin [INN] | 50 μM | MCF7 | 39(39+, 0−) |
The top 10 instances sharing the largest number of significantly affected GOMs with hypoxia treated cells are listed here. For detailed parameter settings: GO mode: BP; permutation time: 1000; P-value: <0.05.